U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C28H31N3O6.ClH
Molecular Weight 542.023
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BENIDIPINE HYDROCHLORIDE

SMILES

Cl.COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(CC4=CC=CC=C4)C3

InChI

InChIKey=KILKDKRQBYMKQX-MIPPOABVSA-N
InChI=1S/C28H31N3O6.ClH/c1-18-24(27(32)36-3)26(21-11-7-12-22(15-21)31(34)35)25(19(2)29-18)28(33)37-23-13-8-14-30(17-23)16-20-9-5-4-6-10-20;/h4-7,9-12,15,23,26,29H,8,13-14,16-17H2,1-3H3;1H/t23-,26-;/m1./s1

HIDE SMILES / InChI
Benidipine is an orally triple L-, T-, and N-type calcium channel blocker for the treatment of hypertension and angina pectoris synthesized and developed by Kyowa Hakko Kogyo Co., Ltd. Benidipine, approved in Japan in November 1991, has become one of the three best selling CCBs and is highly useful as a potent, long-lasting antihypertensive and antianginal agent.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
CONIEL

Approved Use

CONIEL is a calcium channel blocker and extensive clinical testing has demonstrated the sustained efficacy and effectiveness of this agent. A large body of evidence including clinical data and analyses demonstrates that CONIEL protects the heart, kidneys and brain from the effects of hypertension and angina pectoris.

Launch Date

6.8886718E11
Primary
CONIEL

Approved Use

CONIEL is a calcium channel blocker and extensive clinical testing has demonstrated the sustained efficacy and effectiveness of this agent. A large body of evidence including clinical data and analyses demonstrates that CONIEL protects the heart, kidneys and brain from the effects of hypertension and angina pectoris.

Launch Date

6.8886718E11
PubMed

PubMed

TitleDatePubMed
Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
2000 Feb-Mar
Interaction of digoxin with antihypertensive drugs via MDR1.
2002 Feb 15
Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice.
2005 Mar 1
Subdepressor dose of benidipine ameliorates diabetic cardiac remodeling accompanied by normalization of upregulated endothelin system in rats.
2006 May
Patents

Patents

Sample Use Guides

Orally, 4 mg/day
Route of Administration: Oral
The oocytes expressing select Ca channels were cultured for 2 to 4 days and then subjected to electrophysiological measurement. The oocytes were placed in a small chamber perfused with extracellular solution , and Ba2+ currents through expressed channels were measured by the two-microelectrode voltageclamp method. The experimental chamber was 0.5 ml in volume, and it was perfused continuously with the extracellular solution. Typically, oocytes were clamped at a holding potential of 2100, 280, or 260 mV and depolarized to 110 mV for 200 ms every 15 s. Microelectrodes were filled with 3 M KCl, and those showing a resistance of 0.5 to 1.2 VM were used. Benidine was evaluated in concentration range of 0.1 - 100 uM, and demonstrated blocking effect with IC50 of 0.7 uM.
Name Type Language
BENIDIPINE HYDROCHLORIDE
MART.   MI   WHO-DD  
Common Name English
CONIEL
Brand Name English
BENIDIPINE HCL
Common Name English
KW-3049
Code English
Benidipine hydrochloride [WHO-DD]
Common Name English
BENIDIPINE HYDROCHLORIDE [MI]
Common Name English
BENIDIPINE HYDROCHLORIDE [JAN]
Common Name English
BENIDIPINE HYDROCHLORIDE [MART.]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C333
Created by admin on Fri Dec 15 15:52:22 UTC 2023 , Edited by admin on Fri Dec 15 15:52:22 UTC 2023
Code System Code Type Description
ChEMBL
CHEMBL2218858
Created by admin on Fri Dec 15 15:52:22 UTC 2023 , Edited by admin on Fri Dec 15 15:52:22 UTC 2023
PRIMARY
SMS_ID
100000077150
Created by admin on Fri Dec 15 15:52:22 UTC 2023 , Edited by admin on Fri Dec 15 15:52:22 UTC 2023
PRIMARY
FDA UNII
0A6746FWDL
Created by admin on Fri Dec 15 15:52:22 UTC 2023 , Edited by admin on Fri Dec 15 15:52:22 UTC 2023
PRIMARY
MERCK INDEX
m2315
Created by admin on Fri Dec 15 15:52:22 UTC 2023 , Edited by admin on Fri Dec 15 15:52:22 UTC 2023
PRIMARY Merck Index
DRUG BANK
DBSALT001267
Created by admin on Fri Dec 15 15:52:22 UTC 2023 , Edited by admin on Fri Dec 15 15:52:22 UTC 2023
PRIMARY
MESH
C050883
Created by admin on Fri Dec 15 15:52:22 UTC 2023 , Edited by admin on Fri Dec 15 15:52:22 UTC 2023
PRIMARY
CAS
91599-74-5
Created by admin on Fri Dec 15 15:52:22 UTC 2023 , Edited by admin on Fri Dec 15 15:52:22 UTC 2023
PRIMARY
EPA CompTox
DTXSID2049050
Created by admin on Fri Dec 15 15:52:22 UTC 2023 , Edited by admin on Fri Dec 15 15:52:22 UTC 2023
PRIMARY
PUBCHEM
656667
Created by admin on Fri Dec 15 15:52:22 UTC 2023 , Edited by admin on Fri Dec 15 15:52:22 UTC 2023
PRIMARY
NCI_THESAURUS
C81677
Created by admin on Fri Dec 15 15:52:22 UTC 2023 , Edited by admin on Fri Dec 15 15:52:22 UTC 2023
PRIMARY
EVMPD
SUB13004MIG
Created by admin on Fri Dec 15 15:52:22 UTC 2023 , Edited by admin on Fri Dec 15 15:52:22 UTC 2023
PRIMARY